You are here: Industry Insights > Chief Medical Officer

News List

Dr. Paul Burton Joins Moderna as Chief Medical Officer americanpharmaceuticalreview
June 17, 2021
Moderna Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that Paul Burton, M.D., Ph.D., F.A.C.C, M.R.C.S will join the Company as Chief Medical Officer, effective July 6, 2021.
Valneva Appoints Chief Medical Officer contractpharma
August 10, 2020
Valneva SE, a specialty vaccine company focused on prevention of diseases with major unmet needs, has appointed Juan Carlos Jaramillo, MD as chief medical officer and member of the Management Board starting October 1, 2020.
Moberg Pharma Appoints Chief Medical Officer contractpharma
July 31, 2020
Cindy Wong brings extensive international experience in clinical development and registration of new products in several treatment areas.
AMAG Pharma Makes Organization Changes contractpharma
March 05, 2020
Executive Vice President and Chief Medical Officer, Julie Krop to leave the company.
Microsoft welcomes new Chief Medical Officer Dr. David Rhew biospectrumasia
August 21, 2019
David Rhew, M.D., has joined Microsoft's Worldwide Commercial Business (WCB) Healthcare leadership team as the Chief Medical Officer and Vice President of Healthcare.
Roche taps Lilly executive Garraway as chief medical officer expresspharma
August 21, 2019
Swiss drugmaker Roche Holding named Eli Lilly executive Levi Garraway to succeed Sandra Horning as Chief Medical Officer and head of global product development.
C4 Therapeutics Appoints Adam Crystal, M.D., Ph.D. as Chief Medical Officer firstwordpharma
March 15, 2019
C4 Therapeutics(C4T) today announced the appointment of Adam Crystal M.D., Ph.D. as Chief Medical Officer. Dr. Crystal will oversee C4T's activities relating to the clinical development of the company's pipeline of targeted protein degraders.
Immunomedics appoints new CMO biospectrumasia
April 11, 2018
Dr. Iannone brings more than thirteen years of experience in clinical drug development, including the approval of several targeted and immuno-oncology medicines at AstraZeneca/MedImmune and Merck & Co.
England’s chief medical officer calls for better access to genetic testing pharmaceutical-technology
July 10, 2017
England’s chief medical officer professor Dame Sally Davies has highlighted the need for routine access to genetic testing to improve diagnosis and treatment of cancer in the UK.
Adicet Bio Appoints Chief Medical Officer americanpharmaceuticalreview
June 29, 2017
Adicet Bio announced it has appointed Jesse McGreivy, M.D. as its Chief Medical Officer. Dr. McGreivy brings industry experience in successful development of novel cancer therapeutics.

Previous page 1 2 Next page